SRA880 free base

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

SRA880 free base

Specification
Cat. No.
SMD1174
Related Diseases
Depression
Product Name
SRA880 free base
Size
Customizable
Price
Inquiry
Description
SRA880 is a non-peptide somatostatin sst(1) receptor antagonist. SRA880 displayed significantly lower affinity for the other human recombinant somatostatin receptors ( pK(d) < or = 6.0) or a wide range of neurotransmitter receptors, except for the human dopamine D4 receptors. SRA880 positively modulates release of endogenous SRIF, was found to synergize with imipramine in causing antidepressant-like effects in the tail suspension test.
CAS Number
187218-90-2 (free base)
Chemical Formula
C26H32N4O4
Exact Mass
464.2424
Molecular Weight
464.57
Elemental Analysis
C, 67.22; H, 6.94; N, 12.06; O, 13.78
Synonym
SRA880; SRA 880; SRA-880; NVP-SRA880; NVP SRA880; NVPSRA880.
IUPAC/Chemical Name
[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone
InChi Key
INULNSAIIZKOQE-YOSAUDMPSA-N
InChi Code
InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1
SMILES Code
O=C([C@H]1CN(C)[C@]2([H])CC3=CC=CC(OC)=C3C[C@@]2([H])C1)N4CCN(C5=CC=C([N+]([O-])=O)C=C5)CC4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top